Neonatal Abstinence Syndrome

Neurostimulation to Improve NOWS Outcomes

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study

MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome

Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women

The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program

Study to Collect Data for Neonatal Abstinence Syndrome (NAS) and Evaluate the Automated Data Collection Process

A Trial to Determine Weight Gain Benefits of Caloric Supplementation for NAS Infants

An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)

Clinical Trial to Decrease Length of Stay in Infants With Neonatal Abstinence Syndrome With an Exclusive Human Milk Diet

Medication Treatment for Opioid Use Disorder in Expectant Mothers

Efficacy and Outcomes of a Non-Pharmacological Intervention for Neonatal Abstinence Syndrome

Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain

The PATH Home Trial: A Comparative Effectiveness Study of Peripartum Opioid Use Disorder in Rural Kentucky

Physiology and Therapeutic Management of Neonatal Abstinence Syndrome

MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study

Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy

The Effect of Music Therapy on Newborns

Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions

Sound Processing Changes in Babies With Opioid Exposure